首页 | 本学科首页   官方微博 | 高级检索  
     

多西他赛和吉西他滨协同放疗增敏对老年非小细胞肺癌近期疗效观察
引用本文:张明云,韩立杰,李兴德. 多西他赛和吉西他滨协同放疗增敏对老年非小细胞肺癌近期疗效观察[J]. 癌症进展, 2011, 9(2): 196-199
作者姓名:张明云  韩立杰  李兴德
作者单位:沧州市中心医院放疗科,沧州,061001;沧州市中心医院放疗科,沧州,061001;沧州市中心医院放疗科,沧州,061001
摘    要:目的 观察三维适形放疗分别联合多西他赛、吉西他滨治疗老年非小细胞肺癌的疗效及不良反应.方法 将106例经病理学或细胞学证实的老年非小细胞肺癌患者随机分为多西他赛组和吉西他滨组;所有入组患者均先给予2个周期诱导化疗,多西他赛20~25mg/m2,dl、8、15、28大重复;吉西他滨800mg/m2,d1、8、15、28天...

关 键 词:非小细胞肺癌  多西他赛  吉西他滨  放射治疗

Short-term effectiveness and safety of concurrent docetaxel and gemzar combined with radiotherapy for elderly patients with non-small-cell lung cancer
Zhang Mingyun,Han Lijie,Li Xingde. Short-term effectiveness and safety of concurrent docetaxel and gemzar combined with radiotherapy for elderly patients with non-small-cell lung cancer[J]. Oncology Progress, 2011, 9(2): 196-199
Authors:Zhang Mingyun  Han Lijie  Li Xingde
Affiliation:Zhang Mingyun Han Lijie Li Xingde Department of Radiotherapy,Cangzhou Central Hospital,Cangzhou 061001,Chian
Abstract:Objective To evaluate the therapeutic significance of concurrent docetaxel and gemzar combined with radiotherapy for elderly patients with non-small cell lung cancer(NSCLC).Methods Totall 106 pathological or cytologically confirmed elderly patients with NSCLC were randomly divided into docetaxel and gemzar groups.All patients were first given two cycles of induction chemotherapy:docetaxel 20-25mg/m2,d1,d8,d15 and d28;gemzar 800mg/m2,d1,d8,d15 and d28.Responders underwent radiotherapy on the first day of the...
Keywords:non-small-cell lung cancer docetaxel gemzar radiotherapy  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号